We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
Cap. Flow
-$715M
Cap. Flow %
-2.15%
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$29M
2
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$14M
3
MSFT icon
Microsoft
MSFT
+$10.8M
4
META icon
Meta Platforms (Facebook)
META
+$10.5M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$6.72M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$34.4M
2
FRX
FOREST LABORATORIES INC
FRX
+$32.2M
3
XOM icon
ExxonMobil
XOM
+$23.9M
4
WBD icon
Warner Bros
WBD
+$15.4M
5
RTX icon
RTX Corp
RTX
+$13.7M

Sector Composition

Rank Sector Weight
1 Technology 14.81%
2 Financials 14.8%
3 Healthcare 13.73%
4 Industrials 10.72%
5 Energy 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSUN
2926
DELISTED
PACIFIC SUNWEAR OF CAL. INC
PSUN
$98K ﹤0.01%
54,410
+16,500
+44% +$34.4K
SALM
2927
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$97K ﹤0.01%
12,739
– –
YUME
2928
DELISTED
YuMe, Inc.
YUME
$97K ﹤0.01%
19,375
– –
BEBE
2929
DELISTED
Bebe Stores Inc
BEBE
$95K ﹤0.01%
4,080
+580
+17% +$16.4K
XNCR icon
2930
Xencor
XNCR
$1.47B
$94K ﹤0.01%
+10,065
New +$102K
NWY
2931
DELISTED
New York & Co Inc
NWY
$94K ﹤0.01%
30,985
– –
SCMP
2932
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$94K ﹤0.01%
14,408
– –
FRO icon
2933
Frontline
FRO
$8.45B
$93K ﹤0.01%
14,815
– –
GUID
2934
DELISTED
Guidance Software, Inc.
GUID
$93K ﹤0.01%
13,789
– –
KWK
2935
DELISTED
QUICKSILVER RESOURCES INC
KWK
$92K ﹤0.01%
152,400
-6,290
-4% -$9.55K
LCTX icon
2936
Lineage Cell Therapeutics
LCTX
$284M
$91K ﹤0.01%
35,890
– –
TLYS icon
2937
Tilly's
TLYS
$127M
$91K ﹤0.01%
12,127
– –
ONE
2938
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
$91K ﹤0.01%
37,010
-5,200
-12% -$19.7K
STM icon
2939
STMicroelectronics
STM
$47.1B
$89K ﹤0.01%
11,582
-1,600
-12% -$13.3K
TLRA
2940
DELISTED
Telaria, Inc.
TLRA
$89K ﹤0.01%
38,074
– –
NNVC icon
2941
NanoViricides
NNVC
$36.5M
$85K ﹤0.01%
1,420
+103
+8% +$8.09K
PRKR
2942
DELISTED
Parkervision Inc
PRKR
$85K ﹤0.01%
7,459
+1,380
+23% +$17.5K
ULTR
2943
DELISTED
ULTRAPETROL (BAHAMAS) LTD COM STK
ULTR
$84K ﹤0.01%
26,964
+5,500
+26% +$18.2K
GAIN icon
2944
Gladstone Investment Corp
GAIN
$655M
$83K ﹤0.01%
11,700
-80
-0.7% -$598
SYUT
2945
DELISTED
Synutra International, Inc.
SYUT
$78K ﹤0.01%
17,322
+3,000
+21% +$17.8K
RGLS
2946
DELISTED
Regulus Therapeutics
RGLS
$75K ﹤0.01%
91
– –
HIL
2947
DELISTED
Hill International, Inc. Common Stock
HIL
$74K ﹤0.01%
18,545
+175
+1% +$851
ALU
2948
DELISTED
Alcatel-Lucent
ALU
$72K ﹤0.01%
+23,600
New +$80.5K
GALT icon
2949
Galectin Therapeutics
GALT
$203M
$70K ﹤0.01%
13,930
– –
III icon
2950
Information Services Group
III
$204M
$69K ﹤0.01%
18,060
– –
116 117
118
119 120

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q3 2014 Portfolio in Review

As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
  • RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
  • RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
  • RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
  • RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
  • RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.

Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.